Andere Sprachen Baxter International Inc.

Aktien

853815

US0718131099

BAX

Markt geschlossen - Nyse Andere Börsenplätze 22:00:01 24.04.2024			% 5 Tage	% 1. Jan.
40,93 ^USD	-0,22 %		+3,57 %	+5,87 %

23.04.	Edwards Lifesciences Corporation: Fortlaufende Erfolgsgeschichte
11.04.	Baxter International Inc. erweitert Pharma-Portfolio mit neuen injizierbaren Produkten in den USA	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Tentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEO	24.04.
Edwards Lifesciences Corporation: het verhaal gaat verder	23.04.
Edwards Lifesciences Corporation: The story continues	23.04.
Edwards Lifesciences Corporation : La historia continúa	23.04.
Edwards Lifesciences Corporation: la storia continua	23.04.
Edwards Lifesciences Corporation : L’histoire se poursuit	23.04.
Exact Sciences Names Aaron Bloomer CFO	15.04.
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.	11.04.
Baxter International Inc. Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S	11.04.
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors	10.04.
Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period	04.04.
Baxter International Receives US FDA Clearance for Novum IQ Large Volume Infusion Pump	01.04.
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy	01.04.
Baxter International Inc. Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy	01.04.
Baxter International : 2023 Proxy Statement Supplement	28.03.
Baxter to Host Annual Meeting of Stockholders in Virtual Format	27.03.
Baxter International Files Definitive Proxy Statement with Securities and Exchange Commission	25.03.
Baxter International Inc. Enters into Fourth Amendment to the Existing $4.0 Billion Term Loan Credit Facility	21.03.
Baxter International Receives a Shareholder Proposal from John Chevedden	14.03.
Dialysis providers gain as investors focus on cardiac benefits after Ozempic's latest data	05.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Baxter International Inc.

Aktien

853815

US0718131099

BAX

Andere Sprachen

Filter